CIK 0001707502 · Non-accelerated filer<br>Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 900943402
- Phone
- 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | Brooks Gabriel Chief Medical Officer | Sale 10b5-1 | −4,374 | $5.62 | $25K | 97,241 |
| 2026-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise 10b5-1 | +9,750 | 101,615 | ||
| 2026-10-18 | Brooks Gabriel Chief Medical Officer | Option exercise · Restricted Stock Units 10b5-1 | −9,750 | 9,750 | ||
| 2026-10-02 | SMITH IAN F Director | Option exercise | +3,440 | 141,585 | ||
| 2026-10-02 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −3,440 | 3,440 | ||
| 2026-10-01 | Ganot Ilan Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2026-07-02 | SMITH IAN F Director | Option exercise | +3,440 | 138,145 | ||
| 2026-07-02 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −3,440 | 6,880 | ||
| 2026-06-10 | Nagendran Sukumar Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | SMITH IAN F Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Ganot Ilan Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Keresty Georgia Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Freed Martin I Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Kahn Clare Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Sullivan Lynne Marie Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-06-10 | Stone Adam Leo Director | Grant or award · Director Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2026-04-02 | SMITH IAN F Director | Option exercise | +3,441 | 134,705 | ||
| 2026-04-02 | SMITH IAN F Director | Option exercise · Restricted Stock Units | −3,441 | 10,320 | ||
| 2026-03-09 | PERCEPTIVE ADVISORS LLC Director | Grant or award · Pre-Funded Warrant (right to buy) | +8,912,655 | $5.61 | $50.0M | 8,912,655 |
Page 1 of 12 · 223 trades